SIBIONICS presenta GS3 en Melbourne, impulsando un monitoreo de glucosa en sangre más eficiente basado en IA
<p>MELBOURNE, Australia, 31 de agosto de 2026 /PRNewswire/ -- SIBIONICS presentó su innovadora tecnología de sensores y monitoreo de la glucosa en sangre mediante inteligencia artificial en el congreso conjunto IDF-WPR, ADC y Metabolic Diseases 2026, celebrado en Melbourne del 18 al 21 de...</p>
Read original article ↗
Related Articles
Rocket Companies Names Alessio Sanfilippo Chief Executive Officer of Redfin
Former Meta and Intuit executive brings more than two decades of product, data and AI experience to Redfin Click here to
Built by a marketing agency owner tired of watching ad budgets buy spam, gocta.ai qualifies leads in real time, books th
MELBOURNE, Australien, 31. August 2026 /PRNewswire/ -- SIBIONICS präsentierte seine Sensorinnovation und die KI-gestützt